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Introduction
Thoracic endovascular aortic repair (TEVAR) is increasingly ap-
plied in clinical practice as a novel, less invasive treatment for pa-
tients with aortic aneurysms and dissection.
1) Complications are 
rare but have become more common as TEVAR has become more 
popular. Among potential complications, peri-stent graft infection 
(PGI) is difficult to diagnose but potentially catastrophic. Therefore, 
early diagnosis and prompt treatment are critical. Here, we report 
a case of a PGI with secondary aorto-esophageal fistula (AEF) di-
agnosed by computed tomography (CT) and positron emission to-
mography (PET) imaging following endovascular treatment of a 
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contained rupture of a pseudoaneurysm of the descending thoracic 
aorta.
Case
A 50-year-old woman was admitted to the emergency room with 
back pain, nausea and mild fever for longer than 7 days. Three mon-
ths prior, she had undergone stent graft implantation with a 28-
100 mm SEAL stent graft (S&G, Seoul, Korea) for emergent treat-
ment of a contained rupture of a pseudoaneurysm of the descend-
ing thoracic aorta (Fig. 1). The patient had a past history of diabetes 
mellitus for 20 years and had been on hemodialysis for 16 years. 
Two months prior, her right leg was amputated below the knee se-
condary to diabetic foot gangrene. On admission, her temperature 
was 37.8°C. Laboratory findings were as follows: leukocyte count 
of 11.47×10
3/µL with 79.6% neutrophils, hemoglobin of 10.3 g/dL, 
platelet count of 287×10
3/µL, erythrocyte sedimentation rate of 
120 mm/hr and C-reactive protein (CRP) of 2.29 mg/dL. CT imag-
ing showed the stent graft surrounded by soft tissue and air bub-
bles in the descending thoracic aorta compared to a previous, im-
mediate post-operative examination (Fig. 2). PGI was suspected 
based on CT findings. Empirical intravenous vancomycin and tazo-
cin were initiated after obtaining blood cultures but the blood cul-
tures yielded no growth. PET imaging was performed to quantify 
inflammatory activity and assess the extent of infection. This was 367 Sung Ho Lee, et al.
http://dx.doi.org/10.4070/kcj.2012.42.5.366 www.e-kcj.org
notable for increased focal segmental fluorodeoxy-glucose (FDG) up-
take around the mid to distal portions of the stent in the descend-
ing thoracic aorta (Fig. 2). Although aggressive antibiotic therapy 
was administered, a mild fever continued. CRP increased from 2.29 
to 5.01 mg/dL, and hemoglobin decreased from 10.3 to 8.4 g/dL. 
Despite the high risk of mortality for performing an operation due 
to the patient’s poor general condition, we decided to perform the 
surgical removal and aorta repair. A large amount of melena (1.5 L) 
was passed during induction of general anesthesia. Esophago-gas-
tro-duodenoscopy revealed a 1 cm diameter outpouching in the 
mid-esophagus which was covered with clotted blood (Fig. 3). Sur-
gical exploration revealed pus-like discharge around the stent graft, 
with an AEF at the mid third of the esophagus. The infected stent 
graft was removed and replaced with a Rifampicin-soaked 24 mm 
Gelweave graft (Terumo, Tokyo, Japan) with primary closure of the 
AEF. Aorta and vascular graft specimens demonstrated no micro-
organisms on Gram staining. Despite appropriate intensive care, she 
died of intractable shock and respiratory failure 9 days after the 
operation. 
Discussion
Aortic PGI and AEF are uncommon but are frequently associated 
with high mortality and morbidity rates.
2) The incidence of PGI rang-
es between 0.5-5%
3) and secondary AEF after TEVAR ranges from 
0.5% to 1.7%.
4) Prompt diagnosis of these complications is critical 
due to the high mortality rate, ranging from 20% to 40%.
5) It is es-
sential to be suspicious and perform imaging studies, such as CT or 
PET, without delay in suspected cases, especially in patients with 
high risk, as the clinical presentation can be non-specific. Risk fac-
tors for PGI include immunosuppression, postoperative wound in-
fections, diabetes mellitus, cancer and subsequent invasive proce-
dures.
6) Risk factors for AEF include renal dysfunction, pseudo-
aneurysm and emergent TEVAR.
7) The patient with these risk factors 
is required to be closely monitored because of presented nonspe-
A   B  
Fig. 1. Initial CT scan demonstrating a contained rupture of a pseudoaneurysm (A) and a follow-up CT scan after thoracic endovascular aortic repair (B).
A   B   C
Fig. 2. CT scan reveals the stent graft surrounded by soft tissue with air bubbles in the descending thoracic aorta (A). Positron emission tomography scan 
shows increased segmental fluorodeoxyglucose uptake, mostly at sites of abnormal CT findings (B and C), increasing the likelihood of these findings repre-
senting peri-stent graft infection.
Fig. 3. Esophago-gastro-duodenoscopy revealed an outpouching lesion 
covered with clotted blood, suspected of being an aorto-esophageal fistula.368  Stent Graft Infection and Aorto-Esophageal Fistula
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cific symptoms after TEVAR. In our case, the patient had multiple 
risk factors including diabetes mellitus, chronic renal failure, pseu-
doaneurysm and emergent TEVAR. 
Computed tomography is currently the most commonly used 
modality for diagnosing PGI, though it can be difficult to distinguish 
between noninfected and infected grafts on CT.
8) As peri-graft air or 
fluid can be a common postoperative finding during the first 8 weeks 
following surgery,
8) one cannot use these CT findings to definitively 
identify PGI during this time period following TEVAR. PET scanning 
can be a complementary imaging modality for diagnosing PGI us-
ing the focal FDG uptake pattern as a diagnostic criterion.
9) In the 
current case, the CT scan revealed newly developed, loculated peri-
graft air and the PET scan revealed increased FDG uptake around the 
mid to distal portion of the stent in the descending thoracic aorta, 
which was felt to most likely represent a peri-graft infection.
Aorto-esophageal fistula can be both a cause and complication 
of PGI.
10) These two disease entities can exist singly or combined. 
Therefore, if a clinician suspects one of these diseases in a patient, 
they should consider the possible presence of the other as well.
The two most common treatments for graft infections are conser-
vative treatment with suppressive antibiotic therapy and abscess 
drainage or a combination of systemic antibiotic therapy
11) and sur-
gical removal of the infected graft.
12) Of these two, the latter is the 
superior therapeutic approach. The principle in such surgical treat-
ment is total excision of the infected graft with extra-anatomic by-
pass.
12) In the case of PGI with AEF, extensive aortic reconstruction 
and adjunctive surgical repair of the esophageal lesion are essen-
tial. However, surgical treatment is invasive and is frequently asso-
ciated with high mortality rates due to these patients’ frequently 
poor overall medical conditions. Surgical endograft removal should 
be carefully considered based on the clinical and radiologic signs 
of endograft infection as well as the patient’s general condition. 
This report highlights midterm complications that occur rarely fol-
lowing thoracic stent graft implantation. As TEVAR becomes more 
widely used in these complex patients, the operator should be aware 
of rare, potentially fatal complications such as graft infection or AEF 
formation after successful implantation of the stent graft.
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